The government has unveiled plans for how the UK might live with covid-19, but the consequences of the […]

In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer aliu Tue, 03/15/2022 – 11:04

A new way to access scientific papers? admin Mon, 11/15/2021 – 12:01

A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent […]

After trial flop, Exelixis drops plan to pair Cabometyx with Roche’s Tecentriq in early-stage liver cancer fkansteiner Tue, […]

Radiation therapy is one of the cornerstones of cancer therapy. However, some types of tumor respond little or […]

The Otto von Guericke University Magdeburg and the Max Delbrück Center for Molecular Medicine will cooperate in the […]

Recently, Boris Johnson, the UK prime minister announced the government’s “Living with covid” plan. It seems to throw […]

We are being bullied through diktats issued by NHS England and NHS Improvement and delivered by management.1 It […]

Sajid Javid’s suggestion that general practitioners should be employed by hospitals has caused anger by threatening the autonomy […]